Remove Chemotherapy Remove Hospitals Remove Seminar
article thumbnail

Education as the solution to the rare disease ‘diagnostic odyssey’

pharmaphorum

Don said: “If I had gone to a hospital where they had a doctor who worked with scleroderma patients, I would’ve been diagnosed much sooner. The Scleroderma Foundation, he explained, runs annual educational seminars for doctors across the US and Canada, and also publishes national and local newsletters to raise awareness.

article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.